News

Experts Revise AZZ Earnings Forecast Before Imminent Release

Experts Revise AZZ Earnings Forecast Before Imminent Release

Upcoming AZZ Earnings: What Analysts Anticipate

AZZ Inc. (NYSE: AZZ) is preparing to announce its earnings for the second quarter soon, exciting investors and analysts alike. As the anticipation builds, many are eager to see how this Texas-based company will perform in comparison to previous quarters.

Quarterly Earnings Projections

Analysts expect that AZZ will report earnings of $1.32 per share, an increase from the $1.27 reported in the same quarter last year. This shows a promising trend for the company's profitability, indicating a positive trajectory.

Revenue Expectations

The projected revenue for this quarter stands at $411.8 million. Such figures reveal not only consistent growth but also the trust that the market has in AZZ’s operational capabilities. Investors will certainly be keen to see if these projections meet reality.

Recent Developments and Analyst Ratings

On September 24, AZZ revealed the successful completion of its term loan B repricing, signaling strong financial management amidst evolving market conditions. This strategic move adds to their positive standing, making analysts more optimistic about the company's future.

Current Stock Performance

The performance of AZZ shares has been noteworthy, with a recent 2.8% increase to $82.50. Such positive movement suggests investor confidence is high as the earnings call approaches.

Analysts Weigh In: Ratings and Target Prices

As AZZ prepares for its earnings report, several influential analysts have weighed in on the stock:

  • Timna Tanners from Wolfe Research has initiated coverage with a Peer Perform rating, holding an accuracy rate of 67%.
  • Lucas Pipes of B. Riley Securities maintains a Buy rating, recently raising the price target from $89 to $99, showcasing a solid 68% accuracy rate.
  • Stephen Richardson from Evercore ISI Group has rated the stock as Outperform with a target price set at $90 and an accuracy rate of 66%.
  • Michael Heim from Noble Capital Markets upgraded AZZ to Outperform, placing a price target of $95 with a commendable 73% accuracy rate.
  • Laurence Alexander of Jefferies initiated coverage with a Buy rating, projecting a target price of $105, having a strong accuracy rate of 77%.

Investors' Considerations: Confidence in AZZ

The consistent upgrades and positive ratings from these analysts portray a clear message: AZZ stands out as a noteworthy investment opportunity. Investors contemplating adding AZZ stock to their portfolio should pay close attention to these insights from industry experts.

Frequently Asked Questions

What earnings per share is AZZ expected to report?

AZZ is projected to report earnings of $1.32 per share this quarter.

What is the forecasted revenue for AZZ's upcoming earnings?

Analysts forecast that AZZ will generate $411.8 million in revenue for the quarter.

How have AZZ shares performed recently?

AZZ shares recently gained 2.8%, closing at $82.50, showing promising investor confidence.

Which analysts have recently rated AZZ stock?

Analysts from Wolfe Research, B. Riley Securities, Evercore ISI Group, Noble Capital Markets, and Jefferies have recently rated AZZ.

What are the target prices set by analysts for AZZ?

Target prices for AZZ include $99 by B. Riley, $90 by Evercore ISI, $95 by Noble Capital, and $105 by Jefferies.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Ensign Group Faces Class Action Amid Stock Plummet

Updated Category News Views 117

Ensign Group's Recent Troubles Unraveled Let's set the scene: Ensign Group, once riding high at over $170 a share, finds itself knee-deep in allegations that'll make any investor squirm. Now, we're not just talking about a typical market fluctuation here – this is a real smackdown with an 8.2% drop, all thanks to some damning accusations. A Closer Look at Allegations...

Continue Reading
Sirolimus-Coated Balloon Shows Promise in TRANSFORM II

Updated Category News Views 96

Breaking Down the TRANSFORM II Trial Innovation never rests, folks, especially when it comes to treating coronary artery disease. Right on cue, the TRANSFORM II trial's results have hit the airwaves, marking a significant milestone with its implant-free MagicTouch Sirolimus-Coated Balloon (SCB) strategy. Getting the Lay of the Land This wasn't just some backyard...

Continue Reading
ElektraFi Challenges Starlink: Fixed Wireless Gains Edge

Updated Category News Views 93

Revolution or Just Better Options? In the wild west of internet connectivity, where every home is a frontier, ElektraFi is throwing down the gauntlet at the feet of behemoths like Starlink. They're talking big about their fixed wireless network, and in places stretching from Colorado's ski slopes to the dustier reaches of Texas, that talk might just hold some weight. Why...

Continue Reading
IntelliGenome Partners with NL Diagnóstica for TB Battle

Updated Category News Views 127

Breaking New Ground in Tuberculosis Detection When IntelliGenome, a Houston-based developer of CRISPR-based diagnostic tech, teams up with São Paulo's veteran player NL Diagnóstica, you know they're onto something game-changing. This partnership is all about taking the fight against tuberculosis in Brazil to new heights with their CRISPR-Dx™ diagnostic platform. Not...

Continue Reading
Curaleaf Takes Stake in NJ's Boone Town Dispensary

Updated Category News Views 140

Curaleaf's Bold Move in the Garden State Curaleaf Holdings, Inc. is doubling down on its cannabis bet in New Jersey. The acquisition of an equity stake in Boone Town Provisions, located at 677 Myrtle Ave., Boonton, NJ, boosts Curaleaf’s dispensary count to four in the state. The company's not just wandering on the map; it's pinpointing high-performing locations to...

Continue Reading
Downsizing Tips for Seniors: Start Early, Plan Smart

Updated Category News Views 55

When Change Means Home: Addressing Downsizing Head-On It ain't just about shrinking the square footage when longtime homeowners face the dreaded D-word: downsize. Senior folks around New Philadelphia, Ohio are sitting on an emotional and logistical minefield when it comes to shedding that family home. And who else stepped up to bat but local real estate duo Holly Abel...

Continue Reading
MetaOptics Expands U.S. Reach with ADR Programme

Updated Category News Views 123

A Bold Move into the U.S. Market MetaOptics Ltd, the semiconductor optics dynamo out of Singapore, is kicking up some investment dust with their American Depositary Receipts (ADR) Programme aimed squarely at expanding its U.S. footprint. And let me tell you, in the game of international market expansion, that's no rookie maneuver. Why ADR? Why Now? So, why is MetaOptics...

Continue Reading
Illumina's Role in Singapore's Precision Medicine Leap

Updated Category News Views 24

Singapore's Bold Step into Precision Medicine When it comes to revolutionizing healthcare, Singapore isn't content to sit on the sidelines. They've just thrown a serious hat into the ring with the SG-INSIGHT study, a cornerstone of their National Precision Medicine programme. And Illumina, Inc. (NASDAQ:ILMN) is right there in it, gearing up to sequence the genomes of...

Continue Reading
EASE Unlocks $9.5M for AI Medical Expansion in Africa

Updated Category News Views 141

Transforming Healthcare in South Africa and Ghana Expanding into uncharted territories often requires a leap of faith, and EASE Holdings has just taken a substantial one. The medical equipment-as-a-service provider has grabbed a hefty $9.5 million in equity from AAFC Group Inc. The goal? To flood South Africa and Ghana with cutting-edge medical imaging and surgical...

Continue Reading
Hudsonville's Leadership Shift Eyes the Future

Updated Category News Views 147

Hudsonville's New Chapter: Enter CJ Ellens When a firm as storied as Hudsonville Ice Cream elects a new captain at the helm, folks sit up and take notice. CJ Ellens, already well-embedded in the fabric of Hudsonville, is set to steer the ship starting January 1, 2027. This isn't just a revolving door of C-suites, but more like a passing of the torch to someone bred in the...

Continue Reading

Top 5 Most Recently Viewed Articles

Innovative Pool Trends Reshaping Backyard Experiences in 2025

Updated Category News Views 155

Transforming Outdoor Spaces: Latham's Insights on Pool Trends As the pool industry progresses into a new era, homeowners are increasingly drawn to trendy designs and advanced technologies that redefine how swimming pools are perceived and used. The latest innovations are centered around increasing efficiency, enhancing aesthetics, and incorporating luxurious features into...

Continue Reading
National Grid Renewables Partners with Microsoft for Solar Power

Updated Category News Views 100

National Grid Renewables Partners with Microsoft for Solar Power National Grid Renewables has recently completed a significant power purchase agreement (PPA) with Microsoft for its new 250-megawatt (MW) solar project. This initiative promises to harness clean energy while contributing positively to local economies. Investing in Solar Energy for a Sustainable Future The...

Continue Reading
Legal Action Against Iovance Biotherapeutics: Essential Insights

Updated Category News Views 141

Understanding the Recent Legal Developments for Iovance Biotherapeutics In recent news, a notable lawsuit has been filed involving Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), which has raised concerns among its investors. This legal action is significant, as it addresses potential violations of federal securities laws by the biopharmaceutical company and its senior...

Continue Reading
Understanding the P/E Ratio for NetEase's Future Growth

Updated Category News Views 163

Decoding NetEase's P/E Ratio In the current trading session, NetEase Inc. NTES shares are priced at $132.28, reflecting a slight decline of 1.94%. Over the past month, the stock has faced a small decrease of 0.68%. However, on an annual scale, the stock has impressively increased by 47.12%. Investors observing short-term fluctuations may find themselves questioning the...

Continue Reading
IMAX Breaks Records with $53 Million During Chinese New Year

Updated Category News Views 166

IMAX Breaks Records During the Chinese New Year Celebration IMAX Corporation (NYSE: IMAX) has made headlines by achieving an unprecedented box office milestone during the Chinese New Year, raking in an impressive $53 million over the holiday period that concluded recently. This surpasses their previous record of $34 million set just a year prior, marking a staggering 57%...

Continue Reading